The development of recombinant DNA technology during the past thirty years has enabled scientists to isolate, characterize, and manipulate a myriad of different animal, bacterial, and plant genes. This has, in turn, led to the commercialization of hundreds of useful products that have significantly improved human health and well-being. Commercially, these products have been mostly produced in bacterial, fungal, or animal cells grown in culture. More recently, sScientists have begun to develop a wide range of transgenic plants that produce numerous useful compounds. The perceived advantage of producing foreign compounds in plants is that compared to other methods of producing these compounds, plants seemingly provide a much less expensive means of production. A few plant-produced compounds are already commercially available; however, many more are in the production pipeline.
1. Early Engineered Plants
Plants that are resistant to insect predation, damage from plant viruses, and various herbicides (used to prevent the growth of weeds) were genetically engineered beginning ~30–40 years ago, and a number of these engineered plants have been commercially available for many years.
1.1. Insect Resistance
Beginning with the 1940s through the 1970s, several powerful chemical insecticides were developed and employed globally on a massive scale. The use of these insecticides had a dramatic effect in reducing the damage to crop plants that resulted from insect predation. The most effective and most widely use of these chemical insecticides was the compound dichlorodiphenyltrichloroethane or DDT
[1]. Unfortunately, it was eventually discovered that most of these chemical insecticides, and DDT in particular, had negative effects on animals, ecosystems, and humans
[2]. Moreover, many of these chemicals, notwithstanding their apparent effectiveness as insecticides, persisted for many years in the environment and accumulated in increasing concentrations through food chains. With the widespread development of transgenic plants in the early 1980s, scientists began developing plants that were resistant to insect predation
[3,4,5,6,7,8,9,10][3][4][5][6][7][8][9][10]. For the most part, this involved isolating genes encoding bacterial insect-toxigenic proteins from various strains of the bacterium
Bacillus thuringiensis and expressing those genes in transgenic plants; this approach has turned out to be highly effective and without significant negative consequences. In the past 25 years, the availability and commercial use of transgenic plants expressing one or more of several different
B. thuringiensis insecticidal toxins has increased dramatically throughout the US and many other countries of the world
[11]. At the present time, 44 countries worldwide (with the notable exception of countries belonging to the European Union) have given regulatory approval to 40 different genetically engineered crops with insect and herbicide-resistant plants being the most commonly introduced traits
[12]. Currently, regulatory approved
B. thuringiensis-engineered plants include cotton, cowpea, eggplant, maize, poplar, potato, rice, soybean, sugarcane, and tomato.
1.2. Virus Resistance
It has been estimated that there are nearly 2000 known different plant viruses
[13], the great majority of which have a small single-stranded RNA genome (often less than 10 kilobases). These viruses can cause significant damage to crop plants, thereby dramatically reducing plant yields. The viral coat protein is generally the most abundant protein in small single-stranded RNA viruses. Consequently, many transgenic plants have been engineered to express a small single-stranded RNA viral coat protein gene and, as a result are often protected against the systematic spread and the subsequent deleterious effects of that virus
[14,15,16,17,18,19,20][14][15][16][17][18][19][20]. It is believed that the cloned and expressed viral coat protein gene inhibits the expression of the small single-stranded RNA virus through the mechanism of RNA interference (RNAi). In addition, given the similarity in structure and mechanisms of infectivity of many small plant viruses, the abovementioned viral coat protein gene approach has been found to be highly effective for many different plants, including alfalfa, corn, tobacco, tomato, sugar beet, cucumber, papaya, potato, rice, zucchini, soybean, grapevine, squash, pumpkin, plum, and muskmelon, against several different viruses. Moreover, numerous transgenic plants expressing a small single-stranded RNA viral coat protein gene have been approved by regulatory authorities and subsequently commercialized. Unfortunately, the viral coat protein strategy is only effective when transgenic plants are challenged by closely related viruses. Therefore, scientists have sought to develop transgenic plants that are resistant to a broad spectrum of plant viruses. While several different approaches have been attempted to achieve this end, this remains a work in progress.
1.3. Herbicide Resistance
Every year a large portion of worldwide crop production is lost through weed infestation. This loss of productivity notwithstanding, an estimated ~USD 35–40 billion is spent annually by farmers on >100 different chemical herbicides
[21]. Since most herbicides do not discriminate between weeds and crop plants, scientists have developed several different herbicide-resistant crop plants, including plants resistant to triazines, sulfonylureas, imidazolinones, aryloxphenoxypropionates, cyclohexanediones, bromoxynil, phenoxycarboxylic acids, glufosinate, cyanamide, and dalapon. This approach has been so successful that currently ~60% of the transgenic crops that are planted globally have been modified to be herbicide-resistant. However, herbicide-resistant crops do not have a higher yield than non-herbicide-resistant crops
[22]. On the other hand, herbicide-resistant crops are preferred for “improved and simplified weed control, less labour and fuel cost, no-till planting/planting flexibility, yield increase, extended time window for spraying, and in some cases decreased pesticide input”
[23].
Worldwide, the most widely used chemical herbicide is glyphosate (commercially sold as Roundup
®(Bayer, USA), which is claimed by its producer (the Monsanto Corporation, now a division of Bayer) to be safe, cheap, effective, and environmentally friendly
[24]. Transgenic plants that have been shown to be resistant to this herbicide include soybean, corn, canola, tobacco, soybean, petunia, tomato, potato, alfalfa, sorghum, sugar beet, Indian mustard, and cotton. Treatment of plants in the field with glyphosate should kill all (or most) of the weeds while the engineered crop plants are not affected. With the widespread acceptance of this herbicide there is, however, some concern that (i) there is too much dependence upon the use of a single herbicide and, as a result, there are numerous instances of weeds acquiring naturally occurring resistance
[25,26][25][26]; and (ii) some reports have suggested that long term exposure to this herbicide may be toxic or carcinogenic to humans
[27]. Thus, there are some recent literature reports of plants that have been engineered to be resistant to other herbicides that researchers hope will provide an effective alternative to the widespread use of glyphosate
[28,29,30][28][29][30]. However, glyphosate is likely to continue to be the dominant herbicide worldwide until some of these newer approaches can be shown to safe and efficacious in the field with a large number of different transgenic plants
[31].
2. Pharmaceutical Production
Given the fact that many human therapeutic agents are commercially produced in animal cells in culture, the resultant proteins end up being relatively expensive. This is because animal cells in culture grow slowly, do not produce a large biomass, and require specialized fermentation media and equipment. As an alternative to animal cells, scientists have begun to produce a number of therapeutic proteins in genetically engineered plants (in a process that is euphemistically called pharming). A few of these plant-synthesized pharmaceuticals have been approved for human use while several others are currently being tested in clinical trials (
Table 21). For example, one group of scientists showed that transgenic rice could simultaneously produce three functional proteins which together could neutralize HIV-1
[57][32]. These proteins included the monoclonal antibody 2G12, and the lectins griffithsin and cyanovirin-N. This protein mixture enhanced both the activity and the binding of the antibody to the HIV protein gp120, resulting in the virus’s neutralization. Thus, this procedure not only decreased the cost of producing this anti-HIV cocktail, but it also increased the potency of the individual components.
Table 21.
Some plant-synthesized pharmaceuticals.